Halozyme Therapeutics Inc...

61.23
-0.16 (-0.26%)
At close: Apr 15, 2025, 3:59 PM
60.73
-0.82%
After-hours: Apr 15, 2025, 07:55 PM EDT

Halozyme Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
444.09M 281.59M 202.13M 402.71M 129.09M -72.24M -80.33M 62.97M -103.02M
81.31M 84.86M 49.64M 3M 3.28M 4.07M 2.39M 2.16M 2.41M
43.38M 36.62M 24.4M 20.82M 17.2M 34.78M 35.7M 30.67M 25.59M
5.36M 4.1M -9.06M -11.55M 2.52M -19.01M 278.49M 2.04M 5.63M
-979K -10.33M 9.89M 24.61M 13.6M -1.98M 1.7M 17.82M 7.11M
532K 34.51M 40.01M -155.43M 644K 490K -3.08M -257K 560K
-89.28M -38.67M -85.95M 3.74M -108.37M -50.54M -5.87M 20.69M 16.98M
479.06M 388.57M 240.11M 299.44M 55.45M -85.42M -49.5M 134.05M -50.38M
-10.7M -15.29M -4.81M -1.46M -2.5M -4.04M -4.66M -1.35M -3.14M
n/a n/a -999.12M 404.83M 1.08M 1.51M n/a n/a n/a
-647.6M -292.91M -255.21M -652.51M -226.19M -389.76M -311.11M -398.19M -155.41M
395.57M 211.3M 746.13M 247.68M 305.97M 388.25M 318.27M 235.81M 81.78M
n/a n/a 26.01M -404.83M 80.86M -1.51M 7.16M -162.38M -73.63M
-262.72M -96.91M -487M -406.29M 78.35M -5.55M 2.49M -163.73M -76.77M
n/a -13.48M 624.55M 415.81M -19.56M 339.27M -77.52M -15.99M 148.76M
-250M -402.38M -200M -350.06M -150.12M -200M n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
31.14M 7.88M -62.17M 12.11M 63.39M 13.95M 13.72M 12.78M 1.86M
-218.86M -407.99M 362.37M 77.86M -106.28M 153.22M -63.8M 131.66M 150.62M
-2.52M -116.33M 115.48M -28.98M 27.52M 62.24M -110.8M 101.98M 23.47M
468.37M 373.28M 235.3M 297.98M 52.95M -89.46M -54.16M 132.7M -53.52M